Fimasartan is an angiotensin II receptor antagonist indicated for the clinical management of hypertension and heart failure. This category provides a comprehensive range of high-quality reference standards… Read more


![Chemical structure of 2-(2-Butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide compound with 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide (1:1)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-2-Butyl-4-methyl-1-2-1-methyl-1H-tetrazol-5-yl-11-biphenyl-4-ylmethyl-6-oxo-16-dihydropyrimidin-5-yl-NN-dimethylethanethioamide-compound-with-2-2-bu.png&w=3840&q=75)
![Chemical structure of 2-(2-Butyl-4-methyl-6-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-3-yl)methoxy)pyrimidin-5-yl)-N,N-dimethylacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-2-Butyl-4-methyl-6-2-2-trityl-2H-tetrazol-5-yl-11-biphenyl-3-ylmethoxypyrimidin-5-yl-NN-dimethylacetamide.png&w=3840&q=75)
![Chemical structure of 2-(2-Butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1361024-52-3-2-2-Butyl-4-methyl-6-oxo-1-2-1-trityl-1H-tetrazol-5-yl-11-biphenyl-4-ylmethyl-16-dihydropyrimidin-5-yl-NN-dimethylethanethioamide.png&w=3840&q=75)



Fimasartan is an angiotensin II receptor antagonist indicated for the clinical management of hypertension and heart failure. This category provides a comprehensive range of high-quality reference standards necessary for rigorous analytical testing and quality control within pharmaceutical laboratories. The selection includes the active pharmaceutical ingredient, its identified process-related impurities, potential degradation products, and stable isotope-labelled compounds. Chemists and researchers utilize these materials for accurate impurity profiling, the development of stability-indicating methods, and precise quantification during drug product analysis. By providing well-characterized reference standards, this collection supports laboratories in meeting regulatory compliance requirements throughout the various stages of drug development and routine manufacturing.